Showing results (431-440 of 782) with videos related to

Sort By:
Pageof 79
Nature Communications|October 17, 2023
Deep-LASI: deep-learning assisted, single-molecule imaging analysis of multi-color DNA origami structuresSimon Wanninger, Pooyeh Asadiatouei, Johann Bohlen, et al.
Cancer Research|February 24, 2001
Vascular endothelial growth factor receptor-2-blocking antibody potentiates radiation-induced long-term control of human tumor xenograftsS V Kozin, Y Boucher, D J Hicklin, et al.
Biological Chemistry|January 31, 2007
Isolation and characterization of the glutaminyl cyclases from Solanum tuberosum and Arabidopsis thaliana: implications for physiological functionsStephan Schilling, Irene Stenzel, Alex von Bohlen, et al.
Plos Biology|June 12, 2018
DENR-MCTS1 heterodimerization and tRNA recruitment are required for translation reinitiationYasar Luqman Ahmed, Sibylle Schleich, Jonathan Bohlen, et al.
Journal of Immunological Methods|December 14, 1999
Acquired antagonistic activity of a bispecific diabody directed against two different epitopes on vascular endothelial growth factor receptor 2D Lu, H Kotanides, X Jimenez, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 1996
Interleukin 10 inhibits cytokine production of human AML cellsF Westermann, D Kube, B Haier, et al.
Materials (Basel, Switzerland)|January 19, 2020
Alloying and Processing Effects on the Microstructure, Mechanical Properties, and Degradation Behavior of Extruded Magnesium Alloys Containing Calcium, Cerium, or SilverJan Bohlen, Sebastian Meyer, Björn Wiese, et al.
Anesthesiology|April 28, 2004
Role of tyrosine kinase in desflurane-induced preconditioningDirk Ebel, Jost Müllenheim, Hendrik Südkamp, et al.
International Journal of Cancer|February 8, 1995
Suppression of Burkitt's lymphoma tumorigenicity in nude mice by co-inoculation of EBV-immortalized lymphoblastoid cellsJ Wolf, A Draube, H Bohlen, et al.
International Journal of Cancer|March 17, 2001
Locoregional treatment of low-grade B-cell lymphoma with CD3xCD19 bispecific antibodies and CD28 costimulation. I. Clinical phase I evaluationO Manzke, H Tesch, P Borchmann, et al.
Pageof 79